Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A18253 | 27262842 | Acta Biochim Pol | Hepatokines and non-alcoholic fatty liver disease. | 2016 | Details |
| A18292 | 27237577 | Metabolism | Non-alcoholic fatty liver disease and dyslipidemia: An update. | 2016 | Details |
| A18302 | 27227672 | PLoS One | Contribution of Cyclooxygenase End Products and Oxidative Stress to Intrahepatic Endothelial Dysfunction in Early Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A18304 | 27226159 | Sci Rep | Nonalcoholic Fatty Liver Disease is Associated with Increased Carotid Intima-Media Thickness in Type 1 Diabetic Patients. | 2016 | Details |
| A18306 | 27222915 | Ann Med | Liver fat accumulation is associated with circulating PCSK9. | 2016 | Details |
| A18313 | 27219496 | Endocr Pract | AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY. | 2016 | Details |
| A18314 | 27218012 | Curr Hepatol Rep | Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18321 | 27213358 | Int J Mol Sci | The Natural Course of Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A18323 | 27212244 | J Hepatol | Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. | 2016 | Details |
| A18344 | 27194386 | Pituitary | Investigating the role of cortisol and growth hormone in fatty liver development: fatty liver index in patients with pituitary adenomas. | 2016 | Details |
| A18352 | 27185609 | Lancet Diabetes Endocrinol | Phenotypes of prediabetes and stratification of cardiometabolic risk. | 2016 | Details |
| A18394 | 27164417 | Int J Cardiol | Aortic valve sclerosis as a marker of atherosclerosis: Novel insights from hepatic steatosis. | 2016 | Details |
| A18395 | 27164079 | Int J Mol Sci | Vascular Damage in Patients with Nonalcoholic Fatty Liver Disease: Possible Role of Iron and Ferritin. | 2016 | Details |
| A18398 | 27160697 | Dig Liver Dis | Non-alcoholic fatty liver disease fibrosis score and preclinical vascular damage in morbidly obese patients. | 2016 | Details |
| A18420 | 27146015 | Annu Rev Nutr | Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis. | 2016 | Details |
| A18434 | 27142096 | Indian J Gastroenterol | Recurrence of graft steatosis after liver transplantation for cryptogenic cirrhosis in recently commenced liver transplant program. | 2016 | Details |
| A18436 | 27136390 | Mol Nutr Food Res | Nutritional depletion in n-3 PUFA in apoE knock-out mice: A new model of endothelial dysfunction associated with fatty liver disease. | 2016 | Details |
| A18439 | 27134667 | Therap Adv Gastroenterol | Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials. | 2016 | Details |
| A18440 | 27134062 | Nutr Metab Cardiovasc Dis | Insulin resistance, postprandial GLP-1 and adaptive immunity are the main predictors of NAFLD in a homogeneous population at high cardiovascular risk. | 2016 | Details |
| A18448 | 27128911 | Int J Mol Sci | Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic Review. | 2016 | Details |
| A18457 | 27122660 | World J Gastroenterol | Nonalcoholic fatty liver disease as a multi-systemic disease. | 2016 | Details |
| A18462 | 27113292 | Nutr Metab Cardiovasc Dis | The innovative "Bio-Oil Spread" prevents metabolic disorders and mediates preconditioning-like cardioprotection in rats. | 2016 | Details |
| A18472 | 27106721 | Diabetologia | Higher body fat percentage is associated with enhanced temperature perception in NAFLD: results from the randomised Wessex Evaluation of fatty Liver and Cardiovascular markers in NAFLD with OMacor thErapy trial (WELCOME) trial. | 2016 | Details |
| A18473 | 27105827 | Nutr J | Pathophysiological role of host microbiota in the development of obesity. | 2016 | Details |
| A18477 | 27104526 | Int J Mol Sci | NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms? | 2016 | Details |
| A18484 | 27101131 | Diabetologia | Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions. | 2016 | Details |
| A18487 | 27099265 | Eur Heart J | Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease? | 2016 | Details |
| A18492 | 27091791 | J Hepatol | Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications. | 2016 | Details |
| A18494 | 27091184 | Diabetologia | Diagnosis of non-alcoholic fatty liver disease (NAFLD). | 2016 | Details |
| A18501 | 27089331 | Int J Mol Sci | NAFLD and Chronic Kidney Disease. | 2016 | Details |
| A18506 | 27085785 | Metabolism | Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. | 2015 | Details |
| A18507 | 27085779 | Metabolism | Computerized tomography measured liver fat is associated with low levels of N-terminal pro-brain natriuretic protein (NT-proBNP). Multi-Ethnic Study of Atherosclerosis. | 2016 | Details |
| A18518 | 27076501 | Hum Reprod | Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome. | 2016 | Details |
| A18527 | 27069868 | Mol Metab | Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis. | 2016 | Details |
| A18528 | 27068982 | Biochem Soc Trans | Blood triacylglycerols: a lipidomic window on diet and disease. | 2016 | Details |
| A18531 | 27065733 | Ann Gastroenterol | The significance of platelet microparticles in patients with chronic hepatitis C and their association with antiviral treatment and smoking. | 2016 | Details |
| A18532 | 27064133 | Liver Int | Elevated serum ferritin is associated with increased mortality in non-alcoholic fatty liver disease after 16 years of follow-up. | 2016 | Details |
| A18536 | 27063277 | Clin Liver Dis | Nonalcoholic Fatty Liver Disease and Liver Transplantation. | 2016 | Details |
| A18537 | 27063276 | Clin Liver Dis | Extrahepatic Complications of Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18540 | 27063273 | Clin Liver Dis | Effect of Weight Loss, Diet, Exercise, and Bariatric Surgery on Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18541 | 27063272 | Clin Liver Dis | The Progression and Natural History of Pediatric Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A18554 | 28702244 | Clin Diabetes Endocrinol | Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus. | 2016 | Details |
| A18564 | 27055959 | J Clin Lipidol | The associations between apolipoprotein B, A1, and the B/A1 ratio and nonalcoholic fatty liver disease in both normal-weight and overweight Korean population. | 2015 | Details |
| A18566 | 27054361 | Obes Facts | Impact of Apolipoprotein B on Hepatosteatosis in a Population Infected with Hepatitis C Virus: A Cross-Sectional Observational Study. | 2016 | Details |
| A18575 | 27051596 | BBA Clin | Implication of hepatokines in metabolic disorders and cardiovascular diseases. | 2016 | Details |
| A18579 | 27049380 | Int J Mol Sci | Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant. | 2016 | Details |
| A18604 | 27038703 | Dig Liver Dis | Non-alcoholic steatohepatitis and liver transplantation. | 2016 | Details |
| A18613 | 27034174 | J Thromb Thrombolysis | Association between sleep condition and arterial stiffness in Chinese adult with nonalcoholic fatty liver disease. | 2016 | Details |
| A18617 | 27030186 | Ter Arkh | [Evaluation of cardiovascular remodeling and epicardial fat thickness in patients with chronic heart failure and metabolic syndrome]. | 2016 | Details |
| A18629 | 27025201 | Anatol J Cardiol | Aortic flow propagation velocity, epicardial fat thickness, and osteoprotegerin level to predict subclinical atherosclerosis in patients with nonalcoholic fatty liver disease. | 2016 | Details |
| A18631 | 27023537 | Int J Mol Sci | Additive Effect of Non-Alcoholic Fatty Liver Disease on Metabolic Syndrome-Related Endothelial Dysfunction in Hypertensive Patients. | 2016 | Details |
| A18664 | 27005620 | Int J Mol Sci | Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight. | 2016 | Details |
| A18669 | 27003600 | Gastroenterology | Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18679 | 27001641 | Int J Obes (Lond) | Sweeteners and health: findings from recent research and their impact on obesity and related metabolic conditions. | 2016 | Details |
| A18685 | 26998752 | Liver Int | Hepcidin resistance in dysmetabolic iron overload. | 2016 | Details |
| A18688 | 26997540 | Metabolism | Non-alcoholic fatty liver disease and liver transplantation. | 2016 | Details |
| A18693 | 26997011 | Indian J Med Res | Role of γ-glutamyl transferase levels in prediction of high cardiovascular risk among patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A18695 | 26997000 | Clin Cardiol | Fatty Liver, Insulin Resistance, and Obesity: Relationships With Increase in Coronary Artery Calcium Over Time. | 2016 | Details |
| A18714 | 26984260 | Sci Rep | Kcne2 deletion causes early-onset nonalcoholic fatty liver disease via iron deficiency anemia. | 2016 | Details |
| A18719 | 26983474 | Zhonghua Gan Zang Bing Za Zhi | [Nonalcoholic fatty liver disease in the elderly]. | 2016 | Details |
| A18720 | 26983473 | Zhonghua Gan Zang Bing Za Zhi | [Studies on association between nonalcoholic fatty liver disease and hyperuricemia: current status and future prospects]. | 2016 | Details |
| A18722 | 26983471 | Zhonghua Gan Zang Bing Za Zhi | [Advances in diagnosis and treatment of nonalcoholic fatty liver disease]. | 2016 | Details |
| A18725 | 26981209 | World J Cardiol | Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background. | 2016 | Details |
| A18727 | 26980624 | Gastroenterology | Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality. | 2016 | Details |
| A18749 | 26972165 | Best Pract Res Clin Obstet Gynaecol | Metabolic syndrome, diet and exercise. | 2016 | Details |
| A18751 | 26971826 | Gastroenterology | Liver Transplantation for Alcoholic and Nonalcoholic Fatty Liver Disease: Pretransplant Selection and Posttransplant Management. | 2016 | Details |
| A18760 | 26965314 | Lipids Health Dis | Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise review. | 2016 | Details |
| A18782 | 26945512 | Chem Biol Interact | Metformin administration induces hepatotoxic effects in paraoxonase-1-deficient mice. | 2016 | Details |
| A18786 | 26942201 | Biomed Res Int | Advanced Glycation End Products Induce Obesity and Hepatosteatosis in CD-1 Wild-Type Mice. | 2016 | Details |
| A18806 | 26929777 | Therap Adv Gastroenterol | Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trial. | 2016 | Details |
| A18811 | 26925881 | Am J Gastroenterol | Using an Electronic Medical Records Database to Identify Non-Traditional Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18835 | 26911638 | Neurology | Nonalcoholic fatty liver disease is associated with cognitive function in adults. | 2016 | Details |
| A18842 | 26907882 | Nat Rev Gastroenterol Hepatol | Management of NAFLD: a stage-based approach. | 2016 | Details |
| A18847 | 26905407 | Int Urol Nephrol | Correlation between nonalcoholic fatty liver and cardiovascular disease in elderly hemodialysis patients. | 2016 | Details |
| A18871 | 26892520 | Metabolism | Associations of insulin resistance, inflammation and liver synthetic function with very low-density lipoprotein: The Cardiovascular Health Study. | 2015 | Details |
| A18905 | 26876880 | Br J Radiol | Quantification of hepatic and visceral fat by CT and MR imaging: relevance to the obesity epidemic, metabolic syndrome and NAFLD. | 2016 | Details |
| A18951 | 26853695 | Hepatol Res | Association of coronary artery calcification with liver fibrosis in Japanese patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A18962 | 26847197 | BMC Health Serv Res | Association of PNPLA3 rs738409 and TM6SF2 rs58542926 with health services utilization in a population-based study. | 2016 | Details |
| A18972 | 26842974 | J Chin Med Assoc | Lipid-lowering, hepatoprotective, and atheroprotective effects of the mixture Hong-Qu and gypenosides in hyperlipidemia with NAFLD rats. | 2016 | Details |
| A18987 | 26831557 | J Clin Res Pediatr Endocrinol | Assessment of Cardiovascular Parameters in Obese Children and Adolescents with Non-Alcoholic Fatty Liver Disease. | 2015 | Details |
| A19002 | 26825357 | Curr Opin Organ Transplant | Nonalcoholic fatty liver: optimizing pretransplant selection and posttransplant care to maximize survival. | 2016 | Details |
| A19017 | 26817937 | Nutr Metab Cardiovasc Dis | Serum palmitoleate acts as a lipokine in subjects at high cardiometabolic risk. | 2015 | Details |
| A19018 | 26817915 | Medicine (Baltimore) | Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis. | 2016 | Details |
| A19019 | 26817127 | Eksp Klin Gastroenterol | [NONALCOHOLIC FATTY LIVER DISEASE: DIAGNOSTIC, SYMPTOMS, TREATMENT. GUIDELINES WERE APPROVED BY THE XV GASTROENTEROLOGICAL SCIENTIFIC SOCIETY OF RUSSIA IN 2015]. | 2015 | Details |
| A19021 | 26815314 | Liver Int | Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease. | 2016 | Details |
| A19022 | 26815171 | Dig Dis Sci | Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation. | 2016 | Details |
| A19028 | 26812459 | J Adolesc Young Adult Oncol | Metabolic Health in Childhood Cancer Survivors: A Longitudinal Study in a Long-Term Follow-Up Clinic. | 2015 | Details |
| A19035 | 26809873 | Dig Dis Sci | Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A19042 | 26807360 | Quant Imaging Med Surg | Liver fat content is negatively associated with atherosclerotic carotid plaque in type 2 diabetic patients. | 2015 | Details |
| A19049 | 26803429 | Atherosclerosis | Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up. | 2016 | Details |
| A19059 | 26792853 | QJM | Association between non-alcoholic hepatic steatosis and hyper reactive blood pressure response on the exercise treadmill test. | 2016 | Details |
| A19061 | 26791191 | Am J Clin Nutr | Serum aminotransferases in nonalcoholic fatty liver disease are a signature of liver metabolic perturbations at the amino acid and Krebs cycle level. | 2016 | Details |
| A19075 | 26780287 | J Hepatol | Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A19079 | 26775764 | Nat Rev Endocrinol | The Framingham Heart Study--67 years of discovery in metabolic disease. | 2016 | Details |
| A19089 | 26773011 | Adv Nutr | Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes. | 2016 | Details |
| A19096 | 26770322 | Int J Clin Exp Med | Hawthorn leaf flavonoids alleviate nonalcoholic fatty liver disease by enhancing the adiponectin/AMPK pathway. | 2015 | Details |
| A19105 | 26763834 | Hepatol Res | Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease: A meta-analysis study. | 2016 | Details |
| A19111 | 26756786 | Pediatr Res | Associations of TM6SF2 167K allele with liver enzymes and lipid profile in children: the PANIC Study. | 2016 | Details |
| A19114 | 26755867 | World J Gastroenterol | Association between hepatitis B and metabolic syndrome: Current state of the art. | 2016 | Details |
| A19116 | 26754585 | Endocrinol Metab (Seoul) | The Relationship between 10-Year Cardiovascular Risk Calculated Using the Pooled Cohort Equation and the Severity of Non-Alcoholic Fatty Liver Disease. | 2016 | Details |